Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Soluble Neprilysin, NT-proBNP, and Growth-Differentiation-Factor-15 as Biomarkers for Heart Failure in Dialysis Patients

NCT04061811 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT04061811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04061811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Soluble Neprilysin, NT-proBNP, and Growth-Differentiation-Factor-15 as Biomarkers for Heart Failure in Dialysis Patients
Lead sponsor
Hannover Medical School
Phase
Observational
Overall status
Completed
Start date
August 1, 2018
Completion date
February 28, 2019
Enrollment
153 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, heart failure